Evaluation Of A Novel Methodology In The Assessment Of Urethral Function Using SS-RBX.
This study has been completed.
Information provided by:
First received: August 29, 2005
Last updated: May 31, 2011
Last verified: May 2011
SS-RBX will be used to evaluate pharmacodynamic changes in urethral function using a novel methodology
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Primary Purpose: Treatment
|Official Title:||Measurement Of Urethral Function In Women With Stress Urinary Incontinence - Evaluation Of The Sensitivity Of Urethral Reflectometry Compared To Urethral Pressure Profilometry, Using [S,S]-Reboxetine To Detect Pharmacological Augmentation Of Urethral Pressure.|
Resource links provided by NLM:
Further study details as provided by Pfizer:
Primary Outcome Measures:
- To assess the utility of urethral reflectometry in the detection of pharmacologically induced pressure changes in the female urethra.
Secondary Outcome Measures:
- To assess the effect of [S,S]-Reboxetine on urethral function in women with SUI.
|Study Start Date:||December 2005|
|Study Completion Date:||June 2006|
Contacts and Locations